Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Adenosine receptor A2b | ||
Ligand | BDBM50341189 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_740586 (CHEMBL1764849) | ||
IC50 | 13±n/a nM | ||
Citation | Firooznia, F; Cheung, AW; Brinkman, J; Grimsby, J; Gubler, ML; Hamid, R; Marcopulos, N; Ramsey, G; Tan, J; Wen, Y; Sarabu, R Discovery of benzothiazole-based adenosine A2B receptor antagonists with improved A2A selectivity. Bioorg Med Chem Lett21:1933-6 (2011) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Adenosine receptor A2b | |||
Name: | Adenosine receptor A2b | ||
Synonyms: | AA2BR_HUMAN | ADENOSINE A2B | ADORA2B | Adenosine receptor A2B (A2B) | Adenosine receptors A2b | Adenosine receptors; A2a & A2b | ||
Type: | G Protein-Coupled Receptor (GPCR) | ||
Mol. Mass.: | 36341.22 | ||
Organism: | Homo sapiens (Human) | ||
Description: | n/a | ||
Residue: | 332 | ||
Sequence: |
| ||
BDBM50341189 | |||
n/a | |||
Name | BDBM50341189 | ||
Synonyms: | CHEMBL1760896 | trans-N-(7-(N-ethylacetamido)-4-methoxybenzo[d]thiazol-2-yl)-4-(3-(trifluoromethyl)phenylsulfonamido)cyclohexanecarboxamide | ||
Type | Small organic molecule | ||
Emp. Form. | C26H29F3N4O5S2 | ||
Mol. Mass. | 598.657 | ||
SMILES | CCN(C(C)=O)c1ccc(OC)c2nc(NC(=O)[C@H]3CC[C@@H](CC3)NS(=O)(=O)c3cccc(c3)C(F)(F)F)sc12 |r,wU:18.17,wD:21.24,(10.57,-46.93,;10.57,-45.39,;11.9,-44.62,;13.23,-45.39,;14.57,-44.62,;13.24,-46.93,;11.9,-43.08,;10.57,-42.31,;10.57,-40.76,;11.9,-39.99,;11.89,-38.45,;13.22,-37.68,;13.23,-40.76,;14.71,-40.28,;15.62,-41.53,;17.16,-41.53,;17.93,-40.2,;17.16,-38.86,;19.46,-40.19,;20.23,-38.85,;21.77,-38.86,;22.54,-40.2,;21.76,-41.53,;20.23,-41.52,;24.08,-40.2,;24.85,-41.54,;23.5,-42.3,;24.83,-43.07,;26.38,-41.53,;27.14,-42.85,;28.67,-42.85,;29.43,-41.52,;28.65,-40.19,;27.12,-40.21,;29.41,-38.86,;30.95,-38.84,;28.63,-37.53,;30.17,-37.51,;14.71,-42.78,;13.23,-42.31,)| | ||
Structure |